Programme Overview
08:30 – 09:30

Investors Forum breakfast

hosted by PricewaterhouseCoopers

(by invitation only)

Starters, as well as already successful Life Sciences companies, have a need for investment. In the  Investors Forum, companies with the best pitch/business case will be awarded a prize to support their future development. Furthermore, investors will be able to obtain information to support their investment decisions.

Chair: ms ir. Alie Tigchelhoff MBA
 
09:00 – 09:30

Registration open

Arrival of participants and registration.
 
09:30 – 09:35

Welcome

Word of welcome by chairman Dinko Valerio PhD, General Partner Aescap Venture.
 
09:35 – 09:45

Opening

by drs. Henri J.J. Lenferink,
Mayor City of Leiden
.
 
09:45 – 11:45

Financing and Growth Strategies

hosted by Leiden Bio Science Park
Raising money, the impact of public-private partnerships and exit strategies for Life Sciences entrepreneurs.
Chair: Dinko Valerio PhD

Speakers
dr. John de Koning -  Partner Life Sciences Partners

drs. Bert Kuipers - Director Diabetes Fonds

Stuart Laermer MSc, MBA  - Chief Business Officer ThromboGenics Inc.

Ir. Onno van de Stolpe - CEO Galapagos

11:45 – 12:00

 

NGI venture challenge award 2009

hosted by Netherlands Genomics Initiative
Presentations from two nominees

Winner announcement
 
12:00 – 13:15

Exhibition, lunch and Investors Forum
part II

(Investors Forum by invitation only)

 
13:15 – 15:00

Parallel sessions - part I


Workshop 1: Oncology

Chair: dr. Tolleiv Trimborn

Speakers
dr. Janneke Meulenberg - CEO Orca Therapeutics

dr. Gerard Platenburg - CEO ISA Pharmaceuticals

dr. Tolleiv Trimborn - Co-Founder and CEO Therosteon

Kurt Schmidt - CFO and President
Agendia BV


Workshop 2: Cardiovascular Diseases 

Chair: dr. Ad van Gorp, CEO Lead Pharma Holding BV

Speakers
Robbert de Winter MD PhD FESC - professor in clinical cardiology AMC

dr. Hans Stam - CEO Netherlands Heart Foundation

Bart v.d. Berg MSc
- Managing Director DiagnOptics

Rob de Ree - CEO BMEYE B.V.
 
15:00 – 15:30

Break and Exhibition

 
15:30 - 17:15

Parallel sessions - part II


Workshop 3: Infectious Diseases
hosted by Immuno Valley

Chair: prof. Arno Vermeulen PhD

Speakers

prof.dr. Jos van Strijp - Professor of Experimental Microbiology UMC Utrecht

Govert Schouten PhD - CEO Mucosis B.V.

Ronald Kempers MSc - COO Mymetics Corp.

Roland Lageveen PhD - CEO IQ-therapeutics


Workshop 4: Enabling Technologies and services
hosted by Mibiton

Chair: dr.ing. Kees Recourt

Speakers

prof. dr. Edwin Cuppen - CSO InteRNA Technologies

Hans Schikan PharmD - CEO Prosensa

Willem van Weperen MSc MBA - CEO to-BBB technologies BV


drs. Bas Reichert  - Commercial Director BaseClear BV

dr.ir. Alexander Willemse - CEO BioConnection

 
17:15 – 17:35

Plenary closure

Wrap-up by chairman.

Award ceremony for the winner of the Investors Forum.

Announcement of Life Sciences Capitals congress 2010.
 
17:35 – 19:00

Closing reception

hosted by Mibiton


Exhibition